Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-23-028735

Director acquired 80,128 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kiely John Director 2023-05-10 Option exercise +80,128 179,274 D
Derivatives
Kiely John Director 2023-05-09 Grant or award · Restricted Stock Units +76,453 76,453 D
Kiely John Director 2023-05-10 Option exercise · Restricted Stock Units −80,128 0 D
Loading xslF345X04/doc4.xml…